Autopsy report · NCT00253721

Melphalan With BBBD in Treating Patients With Brain Malignancies

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Other competing clinical trials affecting enrollment”

The sponsor’s own words in the registry.

Life of this trial

Registered 7 years 6 months after it had already started.
Ran for about 18 years 7 months before it stopped.
21 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: OHSU Knight Cancer Institute
Sponsor type: University, hospital or other
Conditions: Brain and Central Nervous System Tumors; Lymphoma; Metastatic Cancer
Interventions: Melphalan
Participants: 21
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.